ITRM

Q: What is the price of Iterum Therapeutics (ITRM) today?

A cotação de Iterum Therapeutics (ITRM) hoje está em $ 0.05, com uma variação de The stock began the year trading around $ 0.34 and is currently priced at $ 0.05. negociando na casa dos $ 0.34 e hoje está em $ 0.05. Acompanhe o and track broader market trends directly on the platform.

Q: When does Iterum Therapeutics (ITRM) pay dividends?

Iterum Therapeutics (ITRM) did not pay dividends over the past year.

Q: Is Iterum Therapeutics (ITRM) a good investment?

Atualmente, Iterum Therapeutics (ITRM) está cotada a $ 0.05, com um P/L de -0.06, This represents a -1% premium compared to its historical average P/E. uma variação de -95.44 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -95.44%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Iterum Therapeutics PLC

Price

$ 0.05

return (12m)

-95.44%

p/e

-0.06

p/bv

-0.22

DIVIDEND YIELD

0.00%

ITRM price

ITRM

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ITRM

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

50.00%

3 months

-82.44%

1 year

-95.44%

2 years

-96.81%

5 years

-99.73%

10 years

0.00%

Fundamentals ITRM

review the fundamentals of Iterum Therapeutics shares

P/E

-0.06

Sector: -9.59 Industry: -9.59

P/S (PSR)

4.20

Sector: -138.14 Industry: -138.14

P/BV

-0.22

Sector: 1.99 Industry: 1.99

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-82.95%

Sector: -31.16% Industry: -31.16%

ROE

365.31%

Sector: -31.19% Industry: -31.19%

ROIC

-158.99%

Sector: -2,596.17% Industry: -2,596.17%

NET MARGIN

-100.00%

Sector: -39.99% Industry: -39.99%

GROSS MARGIN

-79.49%

Sector: 37.30% Industry: 37.30%

OPERATING MARGIN

-100.00%

Sector: -39.14% Industry: -39.14%

EV/EBITDA

-0.07

Sector: -10.69 Industry: -10.69

EV/EBIT

-0.07

Sector: -10.50 Industry: -10.50

PRICE-TO-ASSETS

0.05

Sector: 1.43 Industry: 1.43

BVPS

-0.16

Sector: 1.96 Industry: 1.96

EPS

-0.59

Sector: -1.07 Industry: -1.07

EQUITY-TO-ASSETS RATIO

-0.23

Sector: 0.44 Industry: 0.44

LIABILITIES / ASSETS

1.23

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-21.69%

Sector: - Industry: -

Fundamentals ITRM

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	103.71	6.69	6.45%	2.31%	$ 542.92 B	21.76%
PFE	52.78	1.57	2.97%	6.90%	$ 141.82 B	18.60%
ABBV	535.81	-56.32	-10.51%	3.20%	$ 372.39 B	4.63%
NVO	26.47	6.33	23.91%	4.17%	$ 198.78 B	50.15%
AZN	91.32	5.94	6.50%	1.76%	$ 281.27 B	20.15%
GILD	79.63	6.87	8.63%	2.46%	$ 160.94 B	29.04%
BMY	43.39	5.78	13.32%	4.39%	$ 116.17 B	23.30%
ZTS	52.11	9.69	18.59%	2.74%	$ 31.32 B	26.57%
REGN	99.86	2.31	2.31%	0.51%	$ 72.62 B	20.17%
HALO	52.78	36.06	68.32%	0.00%	$ 7.92 B	39.83%
AMGN	96.87	19.17	19.79%	2.96%	$ 176.21 B	21.11%
MCK	55.17	-111.26	-201.68%	0.42%	$ 92.79 B	1.75%
HRMY	53.72	1.92	3.57%	0.00%	$ 1.75 B	15.08%
VRTX	107.61	5.73	5.33%	0.00%	$ 110.99 B	34.53%
CAH	114.64	-17.12	-14.93%	1.05%	$ 45.74 B	0.65%
ADMA	43.06	5.00	11.61%	0.00%	$ 1.95 B	39.59%
BIIB	88.77	1.52	1.71%	0.00%	$ 28.36 B	12.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

ITRM Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Iterum Therapeutics

Iterum Therapeutics PLC

Average Investor10 user rating

4.0 (0 people)

United States

11 years

Founded: 2015

2018

Time since IPO - 8 years

7

Employees

Iterum Therapeutics PLC (United States) is listed on the Nasdaq and has a market capitalization of $1.64 Million, with shareholders equity totaling $-7.38 Millions.

The company employs approximately 7 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Iterum Therapeutics PLC reported $390.00 Thousand in revenue, generating net income of $-26.96 Millions.

Key financial metrics include a P/E ratio of -0.06, a price-to-book (P/B) ratio of -0.22, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ITRM.

Market cap

$ 1.64 Million

Net worth

$ -7.38 Millions

$ -7,380,000.00

Assets

$ 32.50 Millions

$ 32,500,000.00

Total Shares Outstanding

46.00 Millions

46,000,000

Average Daily Trading Volume

$ 2.46 Millions

$ 2,460,346.64

Sector

Health Care

Industry

Biotechnology

ITRM

ITRM revenue and profits

Financial Results ITRM

DRAG THE FRAME TO SEE MORE DATA

ITRM cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 775.97 7,36% (12M)

P/E

55.17

0.42%

ROE

-201.68%

P/BV

-111.26

CAH - Cardinal Health

$ 199.77 31,67% (12M)

P/E

114.64

1.05%

ROE

-14.93%

P/BV

-17.12

JNJ - Johnson & Johnson

$ 228.92 55,22% (12M)

P/E

103.71

2.31%

ROE

6.45%

P/BV

6.69

MRK - Merck & Co.

$ 112.56 51,01% (12M)

P/E

-64.94

2.98%

ROE

-9.23%

P/BV

5.99

AZN - AstraZeneca

$ 183.92 33,83% (12M)

P/E

91.32

1.76%

ROE

6.50%

P/BV

5.94

ABBV - AbbVie

$ 209.41 16,34% (12M)

P/E

535.81

3.20%

ROE

-10.51%

P/BV

-56.32

NVO - Novo Nordisk

$ 44.28 --30,73% (12M)

P/E

26.47

4.17%

ROE

23.91%

P/BV

6.33

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 775.97 7,36% (12 M)

P/L

55.17

0.42%

ROE

-201.68%

P/VP

-111.26

CAH - Cardinal Health

$ 199.77 31,67% (12 M)

P/L

114.64

1.05%

ROE

-14.93%

P/VP

-17.12

JNJ - Johnson & Johnson

$ 228.92 55,22% (12 M)

P/L

103.71

2.31%

ROE

6.45%

P/VP

6.69

MRK - Merck & Co.

$ 112.56 51,01% (12 M)

P/L

-64.94

2.98%

ROE

-9.23%

P/VP

5.99

AZN - AstraZeneca

$ 183.92 33,83% (12 M)

P/L

91.32

1.76%

ROE

6.50%

P/VP

5.94

ABBV - AbbVie

$ 209.41 16,34% (12 M)

P/L

535.81

3.20%

ROE

-10.51%

P/VP

-56.32

NVO - Novo Nordisk

$ 44.28 --30,73% (12 M)

P/L

26.47

4.17%

ROE

23.91%

P/VP

6.33

Frequently Asked Questions

What is the price of Iterum Therapeutics (ITRM) today?

A cotação de Iterum Therapeutics (ITRM) hoje está em $ 0.05, com uma variação de The stock began the year trading around $ 0.34 and is currently priced at $ 0.05. negociando na casa dos $ 0.34 e hoje está em $ 0.05. Acompanhe o and track broader market trends directly on the platform.

When does Iterum Therapeutics (ITRM) pay dividends?

Iterum Therapeutics (ITRM) did not pay dividends over the past year.

Is Iterum Therapeutics (ITRM) a good investment?

Atualmente, Iterum Therapeutics (ITRM) está cotada a $ 0.05, com um P/L de -0.06, This represents a -1% premium compared to its historical average P/E. uma variação de -95.44 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -95.44%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Iterum Therapeutics (ITRM) stock?

You can buy Iterum Therapeutics (ITRM) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ITRM and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Iterum Therapeutics (ITRM) yield today?

Over the past month, Iterum Therapeutics (ITRM) has returned 50.00% — -95.44% over the past year, and -99.73% over the past five years, including price appreciation and dividends.

Nos últimos 12 meses, a empresa pagou um total de $ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Iterum Therapeutics (ITRM) hoje, o investimento total seria de $ 4.50, com base na cotação atual de $ 0.05.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: $ 0.21
Em 5 anos: $ 0.01
Em 10 anos: $ 4.50

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ITRM

Iterum Therapeutics PLC

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ITRM

review the fundamentals of Iterum Therapeutics shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Iterum Therapeutics

Iterum Therapeutics PLC

United States

11 years

2018

7

PROFIT X PRICE ITRM

Financial Results ITRM

ITRM cash flow

Asset, Revenue and Profit Growth - ITRM

ITRM balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions